Genomics

At Genomics plc we are making new possibilities in health, healthcare, and drug discovery a reality, transforming health and lives with the power of genomic prevention. We are an innovative health business dedicated to transforming health, healthcare, and drug discovery through the power of genomics. Genomics plc is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, and to bring new understanding to drug discovery. We were formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford. We generate insights for healthcare systems delivering preventative healthcare; insights for clinicians managing the risk of common diseases for their patients, and insights for pharmaceutical companies about disease processes. Through our Precision Health division, we are leading the new area of genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for common diseases, well ahead of disease manifestation, allowing targeted interventions and tailored screening to prevent disease entirely, or to catch it early when outcomes remain favourable. Through our Therapeutics division, we also partner with leading pharmaceutical companies to incorporate deep understanding of human genetics into research and development for the discovery and validation of new drug targets. Backed by some of the leading investors in life sciences, the Genomics team is a multi-disciplinary group of over 100 scientists, engineers and deployment specialists focused on turning world-leading science into powerful and widely applied healthcare solutions.